Polymorphism in C-C Chemokine Receptor 5 (CCR5) increases susceptibility to Lofgren's syndrome and alters receptor expression as well as functional response

被引:0
|
作者
Karakaya, Bekir [1 ]
Van Moorsel, C. H. M. [1 ]
Veltkamp, M. [1 ]
Benschop, C. [1 ]
Kazemier, K. M. [2 ]
Van der Helm-Van Mil, A. H. M. [3 ]
Huizinga, T. W. J. [3 ]
Grutters, J. C. [1 ]
Rijkers, G. T. [4 ]
机构
[1] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Nieuwegein, Netherlands
[2] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[4] Univ Coll Roosevelt, Dept Sci, Middelburg, Netherlands
关键词
Sarcoidosis; Genetics; Inflammation;
D O I
10.1183/13993003.congress-2021.OA3980
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OA3980
引用
收藏
页数:2
相关论文
共 50 条
  • [31] COVID-19 and susceptibility genes: A possible implication of the C-C type chemokine receptor 5 polymorphism
    Kerek, R.
    Khaled, B. Alshaikh
    CLINICA CHIMICA ACTA, 2024, 558 : 23 - 24
  • [32] CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis
    Petrek, M
    Gibejova, A
    Drabek, J
    Mrazek, F
    Kolek, V
    Weigl, E
    du Bois, RM
    IMMUNOLOGY LETTERS, 2002, 80 (03) : 189 - 193
  • [33] Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys197 and by transmembrane protein aptamers that target it for lysosomal degradation
    Petti, Lisa M.
    Marlatt, Sara A.
    Luo, Yong
    Scheideman, Elizabeth H.
    Shelar, Ashish
    DiMaio, Daniel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (23) : 8787 - 8801
  • [34] Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome
    Gulati, A
    Sacchetti, M
    Bonini, S
    Dana, R
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (05) : 710 - 716
  • [35] C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors
    Hu, Qinxue
    Huang, Xin
    Shattock, Robin J.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 2965 - 2973
  • [36] Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
    Marjan de Groot
    Marcel B. M. Teunissen
    Jean P. Ortonne
    Julien R. Lambert
    Jean M. Naeyaert
    Daisy I. Picavet
    M. Gladys Arreaza
    Jason S. Simon
    Maarten Kraan
    Jan D. Bos
    Menno A. de Rie
    Archives of Dermatological Research, 2007, 299 : 305 - 313
  • [37] Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
    de Groot, Marjan
    Teunissen, Marcel B. M.
    Ortonne, Jean P.
    Lambert, Julien R.
    Naeyaert, Jean M.
    Picavet, Daisy I.
    Arreaza, M. Gladys
    Simon, Jason S.
    Kraan, Maarten
    Bos, Jan D.
    de Rie, Menno A.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (07) : 305 - 313
  • [38] Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells
    Zi, Jie
    Yuan, Shushu
    Qiao, Jianlin
    Zhao, Kai
    Xu, Linyan
    Qi, Kunming
    Xu, Kailin
    Zeng, Lingyu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (04): : 869 - +
  • [39] Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1
    Dogo-Isonagie, Cajetan
    Lam, Son
    Gustchina, Elena
    Acharya, Priyamvada
    Yang, Yongping
    Shahzad-ul-Hussan, Syed
    Clore, G. Marius
    Kwong, Peter D.
    Bewley, Carole A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) : 15076 - 15086
  • [40] Δ32 polymorphism of the chemokine receptor CCR5 in a patient with multifocal motor neuropathy
    Trebst, Corinna
    Heiken, Hans
    Schmidt, Reinhold E.
    Windhagen, Anja
    Staingel, Martin
    MUSCLE & NERVE, 2007, 35 (04) : 541 - 542